Klinische Monatsblatter fur Augenheilkunde 2009-Apr
[Primary or Secondary Prophylaxis of AMD with Anthocyanins?].
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
Lyen an sove nan clipboard la
Mo kle
Abstrè
Bilberry extracts containing anthocyanins have become rather popular within the last 2 years among patients with age-related macular degeneration (AMD) in Switzerland as a medication for primary or secondary prophylaxis. So far human study results concerning safety and efficacy in AMD patients are not available. The present state of the scientific literature concerning the use of anthocyanins with relation to AMD will be analysed in this review.
